Immuron (IMRN) Common Equity (2016 - 2025)

Immuron (IMRN) has reported Common Equity for 10 consecutive years, with $80318.3 the latest figure, recorded in Q3 2025.

• Quarterly Common Equity fell 36.8% year-over-year to $80318.3 in Q3 2025, while the trailing twelve-month figure through Sep 2025 was $80318.3 (down 36.8% YoY) and the FY2025 annual result came in at $80318.3, down 36.8% from the prior year.
• Common Equity retreated to $80318.3 in Q3 2025 per IMRN's latest filing, from $5.7 million in the prior quarter.
• Over the last five years, Common Equity for IMRN reached as high as $19.6 million in Q2 2023 and fell as low as $80318.3 in Q3 2025.
• A 5-year average of $10.1 million and a median of $11.4 million in 2024 frame the typical range for Common Equity.
• Annual changes were most pronounced in 2021 — Common Equity jumped 6307.61% — and 2023, when it tumbled 99.24%.
• Year by year, Common Equity stood at $18.3 million in 2021, then dropped by 10.49% to $16.4 million in 2022, then slumped by 99.24% to $123776.6 in 2023, then jumped by 5799.36% to $7.3 million in 2024, then slumped by 98.9% to $80318.3 in 2025.
• According to Business Quant data, Common Equity over the past three periods registered $80318.3, $5.7 million, and $7.3 million for Q3 2025, Q2 2025, and Q4 2024 respectively.